Cargando…

Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer

MicroRNAs are known to be important in a variety of cancer types. The specific expression and roles of miR-338-3p in the context of gastric cancer, however, remains largely unknown. In this study, we found that miR-338-3p was expressed significantly lower in established/primary human gastric cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jing-jing, Que, Qiao-yan, Xu, Hong-tao, Luo, de-sheng, Sun, Zheng, Ni, Jun-sheng, Que, Hai-feng, Ma, Ji, Wu, Dan, Shi, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119234/
https://www.ncbi.nlm.nih.gov/pubmed/32216582
http://dx.doi.org/10.1177/1533033820905825
_version_ 1783514735431385088
author Zheng, Jing-jing
Que, Qiao-yan
Xu, Hong-tao
Luo, de-sheng
Sun, Zheng
Ni, Jun-sheng
Que, Hai-feng
Ma, Ji
Wu, Dan
Shi, Hua
author_facet Zheng, Jing-jing
Que, Qiao-yan
Xu, Hong-tao
Luo, de-sheng
Sun, Zheng
Ni, Jun-sheng
Que, Hai-feng
Ma, Ji
Wu, Dan
Shi, Hua
author_sort Zheng, Jing-jing
collection PubMed
description MicroRNAs are known to be important in a variety of cancer types. The specific expression and roles of miR-338-3p in the context of gastric cancer, however, remains largely unknown. In this study, we found that miR-338-3p was expressed significantly lower in established/primary human gastric cancer cells than that in human gastric epithelial cells; miR-338-3p is also decreased in human gastric cancer tissues and was positively associated with the worse prognosis of patients with gastric cancer. Enforced expression of miR-338-3p could inhibit cell growth, survival, and proliferation, while inducing cell apoptosis. In addition, miR-338-3p negatively regulated SOX5 expression through directly binding to the 3′-untranslated region of SOX5, and an inverse correlation was found between miR-338-3p and SOX5 messenger RNA expression in gastric cancer tissues. Furthermore, miR-338-3p-induced inactivation of Wnt/β-catenin signaling was greatly abrogated by SOX5 upregulation. Finally, we found that hypoxic conditions were linked with reduced miR-338-3p expression in the context of gastric cancer. In conclusion, miR-338-3p acts as a tumor suppressor in gastric cancer, possibly by directly targeting SOX5 and blocking Wnt/β-catenin signaling. These findings might provide novel therapeutic targets for gastric cancer.
format Online
Article
Text
id pubmed-7119234
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-71192342020-04-13 Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer Zheng, Jing-jing Que, Qiao-yan Xu, Hong-tao Luo, de-sheng Sun, Zheng Ni, Jun-sheng Que, Hai-feng Ma, Ji Wu, Dan Shi, Hua Technol Cancer Res Treat Original Article MicroRNAs are known to be important in a variety of cancer types. The specific expression and roles of miR-338-3p in the context of gastric cancer, however, remains largely unknown. In this study, we found that miR-338-3p was expressed significantly lower in established/primary human gastric cancer cells than that in human gastric epithelial cells; miR-338-3p is also decreased in human gastric cancer tissues and was positively associated with the worse prognosis of patients with gastric cancer. Enforced expression of miR-338-3p could inhibit cell growth, survival, and proliferation, while inducing cell apoptosis. In addition, miR-338-3p negatively regulated SOX5 expression through directly binding to the 3′-untranslated region of SOX5, and an inverse correlation was found between miR-338-3p and SOX5 messenger RNA expression in gastric cancer tissues. Furthermore, miR-338-3p-induced inactivation of Wnt/β-catenin signaling was greatly abrogated by SOX5 upregulation. Finally, we found that hypoxic conditions were linked with reduced miR-338-3p expression in the context of gastric cancer. In conclusion, miR-338-3p acts as a tumor suppressor in gastric cancer, possibly by directly targeting SOX5 and blocking Wnt/β-catenin signaling. These findings might provide novel therapeutic targets for gastric cancer. SAGE Publications 2020-03-27 /pmc/articles/PMC7119234/ /pubmed/32216582 http://dx.doi.org/10.1177/1533033820905825 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Zheng, Jing-jing
Que, Qiao-yan
Xu, Hong-tao
Luo, de-sheng
Sun, Zheng
Ni, Jun-sheng
Que, Hai-feng
Ma, Ji
Wu, Dan
Shi, Hua
Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer
title Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer
title_full Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer
title_fullStr Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer
title_full_unstemmed Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer
title_short Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer
title_sort hypoxia activates sox5/wnt/β-catenin signaling by suppressing mir-338-3p in gastric cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119234/
https://www.ncbi.nlm.nih.gov/pubmed/32216582
http://dx.doi.org/10.1177/1533033820905825
work_keys_str_mv AT zhengjingjing hypoxiaactivatessox5wntbcateninsignalingbysuppressingmir3383pingastriccancer
AT queqiaoyan hypoxiaactivatessox5wntbcateninsignalingbysuppressingmir3383pingastriccancer
AT xuhongtao hypoxiaactivatessox5wntbcateninsignalingbysuppressingmir3383pingastriccancer
AT luodesheng hypoxiaactivatessox5wntbcateninsignalingbysuppressingmir3383pingastriccancer
AT sunzheng hypoxiaactivatessox5wntbcateninsignalingbysuppressingmir3383pingastriccancer
AT nijunsheng hypoxiaactivatessox5wntbcateninsignalingbysuppressingmir3383pingastriccancer
AT quehaifeng hypoxiaactivatessox5wntbcateninsignalingbysuppressingmir3383pingastriccancer
AT maji hypoxiaactivatessox5wntbcateninsignalingbysuppressingmir3383pingastriccancer
AT wudan hypoxiaactivatessox5wntbcateninsignalingbysuppressingmir3383pingastriccancer
AT shihua hypoxiaactivatessox5wntbcateninsignalingbysuppressingmir3383pingastriccancer